|
Symbol
|
P322TQ | WEVLTQ | WXNLTQ | EOJRCH | RMABXV | YOTLTQ | RMBWDV | RMAVSV | RMAXKV | BTJBKB | ZPRLTQ | OCGRCH | LTHCLK | RMBE8V | AAIETQ | OVCRCH | AAXSTQ | OZURCH | PBVRCH | RMA3QV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Holcim/Amrize Basket / Nestlé S.A. / Novartis AG / Swiss RE AG / Zurich Insurance Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | ABB N / Nestlé N / Novartis N / Roche GS / Swiss RE AG | Nestlé / Novartis | Nestlé / Novartis / Roche GS | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Geberit AG / Nestlé S.A. / Novartis AG / UBS Group AG / Zurich Insurance Group AG | ABB / Nestlé / Novartis / Roche GS / Zurich | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
23.12.2025 | 31.03.2028 | 30.06.2028 | 14.01.2026 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 23.12.2025 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 09.07.2027 | 13.07.2026 | 19.07.2027 | 09.06.2026 | 13.09.2027 | 07.07.2026 | 21.04.2027 | 09.11.2026 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
64,42 | 273,39 | 94,1728 | 287,84 | 77,13 | 74,2425 | 63,33 | 159,74 | 54,31 | 47,875 | 45,96 | 58,5776 | 58,7776 | 87,48 | 52,063 | 76,59 | 43,77 | 61,344 | 347,864 | 384,30 |
| rendement max. p.a. | 133,86% | 4,87% | 6,14% | -4,44% | 9,08% | 5,76% | 4,36% | 73,32% | - | 3,60% | 3,12% | 4,14% | 5,42% | 19,45% | 1,38% | 16,78% | 2,82% | 4,17% | 4,20% | 7,43% |
| Demande | - | 101,01 | 95,27 | 100,77 | 96,00 | 96,55 | 100,30 | 79,00 | - | 100,44 | 103,34 | - | - | 92,70 | - | - | 101,52 | 100,76 | - | 97,70 |
| Offre | - | 101,82 | 96,07 | 101,58 | 97,00 | 97,35 | 101,10 | 86,00 | - | 101,25 | 104,17 | - | - | 93,50 | - | - | 102,34 | 101,57 | - | 98,50 |